BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11520102)

  • 1. Anaphylaxis to patent blue dye during sentinel lymph node biopsy for breast cancer.
    Mostafa A; Carpenter R
    Eur J Surg Oncol; 2001 Sep; 27(6):610. PubMed ID: 11520102
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer.
    Aydogan F; Celik V; Uras C; Salihoglu Z; Topuz U
    Am J Surg; 2008 Feb; 195(2):277-8. PubMed ID: 18194680
    [No Abstract]   [Full Text] [Related]  

  • 3. Anaphylaxis reaction of a breast cancer patient to methylene blue during breast surgery with sentinel node mapping.
    Jangjoo A; Forghani MN; Mehrabibahar M; Sadeghi R
    Acta Oncol; 2010 Aug; 49(6):877-8. PubMed ID: 20429734
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer.
    Thevarajah S; Huston TL; Simmons RM
    Am J Surg; 2005 Feb; 189(2):236-9. PubMed ID: 15720998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EJSO 2001; 27:218-9.
    Mostafa A; Carpenter R
    Eur J Surg Oncol; 2002 Jun; 28(4):462. PubMed ID: 12099660
    [No Abstract]   [Full Text] [Related]  

  • 6. Methylene blue as the safest blue dye for sentinel node mapping: emphasis on anaphylaxis reaction.
    Ramin S; Azar FP; Malihe H
    Acta Oncol; 2011 Jun; 50(5):729-31. PubMed ID: 21413854
    [No Abstract]   [Full Text] [Related]  

  • 7. Sentinel lymph node biopsy in management of early breast cancer: Is it rational to omit blue dye injection?
    Kaviani A; Noveiry BB; Noaparast M
    Surgery; 2012 Jul; 152(1):140. PubMed ID: 22386708
    [No Abstract]   [Full Text] [Related]  

  • 8. Can methylene blue only be used in sentinel lymph node biopsy for breast cancer?
    Golshan M; Nakhlis F
    Breast J; 2006; 12(5):428-30. PubMed ID: 16958960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of methylene blue dye in localization of sentinel lymph node in breast cancer patients.
    Nour A
    Breast J; 2004; 10(5):388-91. PubMed ID: 15327490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node mapping of breast cancer: a case-control study of methylene blue tracer compared to isosulfan blue.
    Eldrageely K; Vargas MP; Khalkhali I; Venegas R; Burla M; Gonzalez KD; Vargas HI
    Am Surg; 2004 Oct; 70(10):872-5. PubMed ID: 15529840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blue-dye intraoperative sentinel lymph node mapping in early non-small cell lung cancer.
    Rzyman W; Hagen OM; Dziadziuszko R; Kobierska-Gulida G; Karmolinski A; Lothe MI; Paleczka W; Murawski M; Jastrzebski T; Kopacz A; Jassem J; Skokowski J
    Eur J Surg Oncol; 2006 May; 32(4):462-5. PubMed ID: 16504458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meeting surgical necessities for sentinel lymph node biopsy in breast cancer: experience with methylene blue in a Colombian hospital.
    Angarita FA; Acuna SA; Cervera S; Torregrosa L; Tawil M
    Breast J; 2012; 18(6):618-9. PubMed ID: 23110749
    [No Abstract]   [Full Text] [Related]  

  • 13. Sentinel lymph node biopsy in early breast cancer surgery--working with the risks of vital blue dye to reap the benefits.
    White V; Harvey JR; Griffith CD; Youssef M; Carr M
    Eur J Surg Oncol; 2011 Feb; 37(2):101-8. PubMed ID: 21195576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application of methylene blue dye to sentinel lymph node biopsy in breast cancer and its influencing factors].
    Huang XY; Wu J; Liu ZB; Zhang JX; Han QX; Xu WP; Ping B; Yang WT; Shen ZZ; Shao ZM
    Ai Zheng; 2007 Oct; 26(10):1133-7. PubMed ID: 17927887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaphylactoid reactions to isosulfan blue dye during breast cancer lymphatic mapping in patients given preoperative prophylaxis.
    Raut CP; Daley MD; Hunt KK; Akins J; Ross MI; Singletary SE; Marshall GD; Meric-Bernstam F; Babiera G; Feig BW; Ames FC; Kuerer HM
    J Clin Oncol; 2004 Feb; 22(3):567-8. PubMed ID: 14752082
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anaphylactic reaction to patent blue in sentinel node biopsy].
    Galatius H; Holtveg HM; Følsgård SL
    Ugeskr Laeger; 2003 Aug; 165(34):3242-3. PubMed ID: 12970997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and technical success of methylene blue dye for lymphatic mapping in breast cancer.
    Zakaria S; Hoskin TL; Degnim AC
    Am J Surg; 2008 Aug; 196(2):228-33. PubMed ID: 18367146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaphylactic response to blue dye during sentinel lymph node biopsy.
    Bézu C; Coutant C; Salengro A; Daraï E; Rouzier R; Uzan S
    Surg Oncol; 2011 Mar; 20(1):e55-9. PubMed ID: 21074413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylene blue dye--a safe and effective alternative for sentinel lymph node localization.
    Varghese P; Abdel-Rahman AT; Akberali S; Mostafa A; Gattuso JM; Carpenter R
    Breast J; 2008; 14(1):61-7. PubMed ID: 18186867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sentinel nodes identification efficacy prognostic criteria in breast cancer].
    Kokhreidze ID; Nemsadze GG; Gersamiia GK; Dzagnidze GB; Dzhandzhaliia MT
    Georgian Med News; 2005 Feb; (119):31-4. PubMed ID: 15834176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.